Why Eli Lilly is Winning the Weight Loss War

There's a clear victor in the weight loss wars and it's Eli Liy. For about a century, Eli Liy and Novo Nordisk have competed in the diabetes market. Both were insulin giants.Neither clearly won. When the GLP1 boom began, investors assumed that a rising tide would lift both boats. Both companies already had blockbuster diabetes drugs.think Ompeic and Mount Jarro. So the thinking was that both companies would do quite well in the weight loss market too. At first, Novo Nordisk pulled ahead.The company won appr ...